Evolution of the Average Target: Grifols, S.A.

Evolution of the Target Price: Grifols, S.A.

Changes in Analyst Recommendations: Grifols, S.A.

549355bf4728c9efd8907bc0ad0.mqPVzdPDZSKs5gh_tyvDcog8n9-E9OBa5iujSFMfstY.z8ua_eX7MBDqoXxShWD7LbhS-avIuJU013HKCxRvg7ndz6G9pIoHW8uSSQ~3f0a8ac540d8922cc883204fc7a8a15c
08-20 Cancer vaccines finally garner the spotlight Alphavalue
07-29 Grifols: Improving profitability and FCFs relieve investors Alphavalue
07-27 Spanish stocks - Factors to watch on July 27 RE
07-14 Where would AI lead Pharma in the long run? Alphavalue
06-19 Bestinver Securities Lowers Grifols PT, Keeps at Buy MT
05-25 CaixaBank Trims Grifols' PT, Maintains Buy Rating MT
05-21 Spanish stocks - Factors to watch on May 21 RE
05-08 Grifols: FCFs didn't impress; rebuilding trust isn't going to be easy Alphavalue
04-06 AlphaValue/Baader Europe Reduces Grifols' PT, Keeps at Buy MT
04-06 AlphaValue/Baader Europe Lowers Grifols Forecasts Amid Lack of FY26 Sales Growth Guidance MT
04-06 Grifols: May struggle to walk the talk Alphavalue
03-27 Grifols: IPO plans for a subsidiary don't smell right Alphavalue
03-10 Morgan Stanley Downgrades Grifols to Equalweight, Cuts PT MT
02-27 Grifols: Decent end to 2025, but suspicions rise over future execution abilities Alphavalue
11-06 Grifols lifts 2025 targets but fibrinogen delay and forex drag weigh on outlook Alphavalue
11-05 Invest Securities raises target price for Grifols Zonebourse
11-05 Spanish stocks - Factors to watch on Nov 5 RE
25-10-09 Spain's High Court summons Gotham City, GIP managers for market-related offence regarding Grifols RE
25-09-29 Grifols creates strategy committee to advise board RE
25-09-17 Alantra Equities Upgrades Grifols to Buy, Raises PT MT
25-08-26 AlphaValue/Baader Europe Upgrades Grifols to Buy, Lifts PT MT
25-07-31 BofA Keeps Grifols at Buy as Strong Q2 Offsets Currency Headwinds MT
25-07-30 Grifols: Exhibiting confidence by reinstating dividends Alphavalue
25-05-28 Barclays Keeps Grifols at Overweight on Growing Positive Momentum MT
25-05-27 Grifols: Governance and operational improvements are worthy of notice Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+8.21%
-22.39%
+1.17%
+40.74%
+36.95%
+10.53%
+1.94%
+33.64%
+12.06%
Average +13.65%
Weighted average by Cap. +10.90%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
9.542EUR
Average target price
14.76EUR
Spread / Average Target
+54.67%
High Price Target
23.00EUR
Spread / Highest target
+141.04%
Low Price Target
9.000EUR
Spread / Lowest Target
-5.68%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!